SynthesisFrontiers in public health2025

Nirsevimab for preventing respiratory syncytial virus lower respiratory tract infections in infants: a systematic review and meta-analysis.

Samira Soudani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.